Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04109846 · ClinicalTrials.gov registry record · NA
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
A NA study of Aneuploidy and Mosaicism, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT04109846: Recruiting NA study of Aneuploidy and Mosaicism, sponsored by Stanford University.
NCT04109846 is a NA study of Aneuploidy and Mosaicism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 300 participants, below the 1,398-participant average among 5 other Aneuploidy trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04109846, a NA study of Aneuploidy and Mosaicism, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Primary Outcome
Number participants who undergo embryo transfers that lead to a positive pregnancy test
Conditions Studied
Interventions
- OTHER Non-euploid embryo transfer
- OTHER Euploid Transfer
Study Locations (1)
California
- Stanford Fertility and Reproductive Medicine Center - Sunnyvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-04-11 |
| Est. Completion | 2039-04-01 |
| Phase | NA |
What NCT04109846 shows while recruiting
NCT04109846 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,398-participant average among 5 other Aneuploidy trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Aneuploidy appearing as the primary indexed condition, and to 2 interventions - of which Non-euploid embryo transfer is the first listed.
NCT04109846 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04109846 about?
NCT04109846 is a clinical study titled "Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos". To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental iss...
What is the current status of trial NCT04109846?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-04-11. Estimated completion is 2039-04-01.
What conditions does trial NCT04109846 study?
This clinical trial studies the following conditions: Aneuploidy, Mosaicism, Pregnancy Outcome.
What interventions are being tested in trial NCT04109846?
The interventions under investigation include: Non-euploid embryo transfer (OTHER), Euploid Transfer (OTHER).
Who is sponsoring clinical trial NCT04109846?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04109846 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneuploidy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GEM: Impact of a Video Education Tool on Decisional Conflict Among Prenatal Patients
ACTIVE NOT RECRUITING · NA
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Multi-center Study to Validate niPGT-A
COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
COMPLETED
-
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI